WikiDoc Resources for HAS-BLED score |
Articles |
---|
Most recent articles on HAS-BLED score Most cited articles on HAS-BLED score |
Media |
Powerpoint slides on HAS-BLED score |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on HAS-BLED score at Clinical Trials.gov Trial results on HAS-BLED score Clinical Trials on HAS-BLED score at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on HAS-BLED score NICE Guidance on HAS-BLED score
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on HAS-BLED score Discussion groups on HAS-BLED score Patient Handouts on HAS-BLED score Directions to Hospitals Treating HAS-BLED score Risk calculators and risk factors for HAS-BLED score
|
Healthcare Provider Resources |
Causes & Risk Factors for HAS-BLED score |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editors-in-Chief: Gregory Lip, MD [1] and C. Michael Gibson, M.S., M.D. [2] Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[3]
The HAS-BLED score is a therapeutic bleeding risk stratification score for those on oral anticoagulants in atrial fibrillation[1]. It is recommended by the new European Society of Cardiology guidelines and the Canadian guidelines on atrial fibrillation management.[2][3] This score would help as a potential practical tool in clinical decision making, rather than 'guessing' the bleeding risk. Also, the HAS-BLED score makes clinicians think about addressing any correctable bleeding risk factors (eg. uncontrolled hypertension, coadministration of NSAIDs or aspirin, etc). It is matched to the CHA2DS2-VASc score used for stroke risk stratification. In a recent article validating the score, diabetes and left ventricular dysfunction were identified as additional risk factors for bleeding.[4]
Please check the boxes that apply to your patient to calculate the HAS-BLED score for bleeding:
|month=
ignored (help)